Should I Take Entresto?

When It Makes Sense

• Good fit: You have moderate to severe heart failure (NYHA class II‑III) and your blood pressure, while on the lower side, remains above the minimum threshold (usually >90/60 mmHg) and can be safely monitored by a cardiologist.
• Good fit: You are already on a regimen of blood‑pressure‑lowering drugs and your physician plans to substitute one of them with Entresto to simplify therapy while still maintaining safe blood‑pressure levels.

When You Should Avoid It

• Warning sign: Your systolic blood pressure consistently falls below 90 mmHg or you experience symptoms of hypotension (dizziness, fainting) even without medication.
• Warning sign: You have a history of angio‑edema related to ACE inhibitors or ARBs, which increases the risk of a similar reaction with Entresto.

Pros and Cons

Pros

• Entresto has been shown to reduce cardiovascular death and heart‑failure hospitalizations compared with standard ACE‑inhibitor therapy.
• It combines two mechanisms—neprilysin inhibition and angiotensin‑receptor blockade—providing a broader therapeutic effect on cardiac remodeling.

Cons

• The medication can lower blood pressure further, potentially causing symptomatic hypotension, especially in patients who already have low baseline readings.
• It carries risks of hyperkalemia, renal dysfunction, and angio‑edema, requiring regular laboratory monitoring.

Decision Checklist

• Is your current systolic blood pressure reliably above the safe minimum (generally >90 mmHg) under resting conditions?
• Do you have a clear clinical indication for Entresto, such as reduced‑ejection‑fraction heart failure, that outweighs the hypotension risk?
• Have you discussed a monitoring plan (blood pressure checks, labs) with your healthcare provider before starting?

Alternatives to Consider

Other evidence‑based options for heart‑failure management include ACE inhibitors, ARBs, beta‑blockers, mineralocorticoid‑receptor antagonists, and lifestyle interventions such as sodium restriction and supervised exercise. For patients with low blood pressure, low‑dose ACE inhibitors or ARBs may be titrated more cautiously, and device therapy (e.g., ICD, CRT) may be explored when appropriate.

Final Recommendation

Entresto can be a valuable therapy for individuals with heart failure even when blood pressure is on the low side, provided the numbers stay above a clinically safe threshold and the patient is under close supervision. If you are symptomatic from hypotension, have a history of angio‑edema, or cannot commit to regular monitoring, discuss alternative heart‑failure regimens with your doctor. Always involve a qualified healthcare professional before making or changing medication decisions.